Sigma Granted Patent for REDTaq™ DNA Polymerase Product Line
News Sep 16, 2005
Sigma, a division of Sigma- Aldrich Corporation has announced that the U.S. Patent and Trademark Office granted the Company U.S. Patent Number 6,942,964, entitled "Tracer Reagents that Enhance Reaction-Product Analysis," covering the array of direct-load RED enzymes already being offered in Sigma's PCR product line.
REDTaq™ products are a blend of various DNA polymerases combined with an inert red dye. The dye allows quick visual confirmation of enzyme addition and reaction homogeneity.
The sample can also be loaded directly onto an agarose gel for electrophoresis following PCR. The red dye has no effect on downstream applications.
"Our RED enzymes have been successful as an added convenience and time-saver to the research community," said Keith Jolliff, Director of Strategic Marketing in the Biotechnology Business Unit at Sigma-Aldrich.
"This patent adds to our technology portfolio and expands our leadership in life sciences and high technology."
Sigma claims that, the RED enzyme product line covers all areas of PCR including routine amplification, hot start, long and accurate, and genomic DNA amplification.
The enzymes come in both a stand-alone format as well as a ReadyMix™ formula for added convenience.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE